DIN 02557347 — TZIELD 2 MG
TZIELD is a solution of Teplizumab marketed by SANOFI-AVENTIS CANADA INC. The full Teplizumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02557347
- Brand name
- TZIELD
- Active ingredient
- Teplizumab
- Strength
- 2 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- SANOFI-AVENTIS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- CD3-directed monoclonal antibody (immunomodulator)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.